Valley National Advisers’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-36
Closed -$2K 732
2017
Q4
$2K Hold
36
﹤0.01% 579
2017
Q3
$2K Hold
36
﹤0.01% 578
2017
Q2
$2K Hold
36
﹤0.01% 542
2017
Q1
$2K Buy
+36
New +$1.77K ﹤0.01% 546

Other funds holding BIVV

Valley National Advisers's BIVV Position: Q1 2018 in Review

Valley National Advisers sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 36 shares — an estimated $2K sold.

Valley National Advisers first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Valley National Advisers reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Valley National Advisers sold 36 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $2K.
  • Valley National Advisers first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Valley National Advisers's Bioverativ Inc. Common Stock position peaked at $2K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Valley National Advisers's 13F filing for Q1 2018, filed 19 Apr 2018.